154 related articles for article (PubMed ID: 35191140)
1. Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease.
Parta M; Cuellar-Rodriguez J; Gea-Banacloche J; Qin J; Kelly C; Zerbe CS; Holland SM; Malech HL; Kang EM
Transpl Infect Dis; 2022 Apr; 24(2):e13815. PubMed ID: 35191140
[TBL] [Abstract][Full Text] [Related]
2. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
3. Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
Jing Y; Li J; Yuan L; Zhao X; Wang Q; Yu L; Zhou D; Huang W
Clin Transplant; 2016 Mar; 30(3):263-9. PubMed ID: 26701371
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yanez San Segundo L; Pabst T; Özçelik T; Klyasova G; Donnini I; Wu D; Gülbas Z; Zuckerman T; Botelho de Sousa A; Beguin Y; Xhaard A; Bachy E; Ljungman P; de la Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
Clin Infect Dis; 2017 Nov; 65(11):1819-1828. PubMed ID: 29020364
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
Petteys MM; Kachur E; Pillinger KE; He J; Copelan EA; Shahid Z
J Oncol Pharm Pract; 2020 Apr; 26(3):632-640. PubMed ID: 31423947
[TBL] [Abstract][Full Text] [Related]
6. Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.
Kaya AH; Tekgündüz E; Duygu F; Koca D; Bekdemir F; Batgi H; Ulu Uncu B; Yiğenoğlu TN; Dal MS; Çakar Kızıl M; Altuntaş F
Balkan Med J; 2017 Apr; 34(2):132-139. PubMed ID: 28418340
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
Ogura S; Kimura M; Takagi S; Mitsuki T; Yuasa M; Kageyama K; Kaji D; Nishida A; Taya Y; Ishiwata K; Yamamoto H; Asano-Mori Y; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):941-948. PubMed ID: 33185742
[TBL] [Abstract][Full Text] [Related]
8. Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease.
Parta M; Hilligoss D; Kelly C; Kwatemaa N; Theobald N; Zerbe CS; Holland SM; Malech HL; Kang EM
J Clin Immunol; 2020 May; 40(4):619-624. PubMed ID: 32314173
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study.
Grunebaum E; Arnold DE; Logan B; Parikh S; Marsh RA; Griffith LM; Mallhi K; Chellapandian D; Lim SS; Deal CL; Kapoor N; Murguía-Favela L; Falcone EL; Prasad VK; Touzot F; Bleesing JJ; Chandrakasan S; Heimall JR; Bednarski JJ; Broglie LA; Chong HJ; Kapadia M; Prockop S; Dávila Saldaña BJ; Schaefer E; Bauchat AL; Teira P; Chandra S; Parta M; Cowan MJ; Dvorak CC; Haddad E; Kohn DB; Notarangelo LD; Pai SY; Puck JM; Pulsipher MA; Torgerson TR; Malech HL; Kang EM; Leiding JW
J Allergy Clin Immunol; 2024 May; 153(5):1423-1431.e2. PubMed ID: 38290608
[TBL] [Abstract][Full Text] [Related]
10. Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.
Mikulska M; Raiola AM; Galaverna F; Balletto E; Borghesi ML; Varaldo R; Gualandi F; Giannoni L; Pastori G; Giacobbe DR; Signori A; Del Bono V; Viscoli C; Bacigalupo A; Angelucci E
Biol Blood Marrow Transplant; 2018 Jan; 24(1):109-118. PubMed ID: 28860000
[TBL] [Abstract][Full Text] [Related]
11. Impact of Preemptive Granulocyte Infusions During Febrile Neutropenia in Patients Colonized with Carbapenem-Resistant Gram-Negative Bacteria Undergoing Haploidentical Transplantation.
Jaiswal SR; Bhakuni P; Bhagwati G; Joy A; Chakrabarti A; Chakrabarti S
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1621-1628. PubMed ID: 31048086
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan.
Yanagimachi M; Kato K; Iguchi A; Sasaki K; Kiyotani C; Koh K; Koike T; Sano H; Shigemura T; Muramatsu H; Okada K; Inoue M; Tabuchi K; Nishimura T; Mizukami T; Nunoi H; Imai K; Kobayashi M; Morio T
Front Immunol; 2020; 11():1617. PubMed ID: 32849547
[TBL] [Abstract][Full Text] [Related]
13. High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease.
Yanir AD; Hanson IC; Shearer WT; Noroski LM; Forbes LR; Seeborg FO; Nicholas S; Chinn I; Orange JS; Rider NL; Leung KS; Naik S; Carrum G; Sasa G; Hegde M; Omer BA; Ahmed N; Allen CE; Khaled Y; Wu MF; Liu H; Gottschalk SM; Heslop HE; Brenner MK; Krance RA; Martinez CA
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1643-1650. PubMed ID: 29630926
[TBL] [Abstract][Full Text] [Related]
14. [Infection in patients with neutropenia that undergo an autologous peripheral blood stem cell transplant due to breast cancer].
Palau J; Picón I; Angel Climent M; Martí R; Aznar E; Carmen Sanjuán M; Máiquez J
Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):422-7. PubMed ID: 11709119
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.
Seger RA; Gungor T; Belohradsky BH; Blanche S; Bordigoni P; Di Bartolomeo P; Flood T; Landais P; Müller S; Ozsahin H; Passwell JH; Porta F; Slavin S; Wulffraat N; Zintl F; Nagler A; Cant A; Fischer A
Blood; 2002 Dec; 100(13):4344-50. PubMed ID: 12393596
[TBL] [Abstract][Full Text] [Related]
16. Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.
Rönkkö R; Juutilainen A; Koivula I; Vänskä M; Nousiainen T; Jantunen E; Hämäläinen S
Infect Dis (Lond); 2018 Jun; 50(6):436-442. PubMed ID: 29303041
[TBL] [Abstract][Full Text] [Related]
17. A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease.
Khandelwal P; Bleesing JJ; Davies SM; Marsh RA
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2011-2018. PubMed ID: 27543157
[TBL] [Abstract][Full Text] [Related]
18. Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update.
Lehrnbecher T; Robinson PD; Ammann RA; Fisher B; Patel P; Phillips R; Beauchemin MP; Carlesse F; Castagnola E; Davis BL; Elgarten CW; Groll AH; Haeusler GM; Koenig C; Santolaya ME; Tissing WJE; Wolf J; Alexander S; Hu H; Dupuis LL; Sung L
J Clin Oncol; 2023 Mar; 41(9):1774-1785. PubMed ID: 36689694
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy.
Arnold DE; Chellapandian D; Parikh S; Mallhi K; Marsh RA; Heimall JR; Grossman D; Chitty-Lopez M; Murguia-Favela L; Gennery AR; Boulad F; Arbuckle E; Cowan MJ; Dvorak CC; Griffith LM; Haddad E; Kohn DB; Notarangelo LD; Pai SY; Puck JM; Pulsipher MA; Torgerson T; Kang EM; Malech HL; Leiding JW
J Clin Immunol; 2022 Jul; 42(5):1026-1035. PubMed ID: 35445907
[TBL] [Abstract][Full Text] [Related]
20. Haploidentical hematopoietic stem cell transplantation for a case with X-linked chronic granulomatous disease.
Zhou L; Dong LJ; Gao ZY; Yu XJ; Lu DP
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27885760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
